Cibinqo
My Prescription
Payment
Select pharmacy
$5,929.57
Print or send this coupon to your phone
AlbertsonsPowered byAbout Cibinqo
Drug Details
Abrocitinib, marketed as Cibinqo, is prescribed for the treatment of moderate-to-severe atopic dermatitis, commonly known as eczema, in individuals aged 12 years and older who have not responded to other therapies. This medication is taken orally, typically once a day. Abrocitinib belongs to a category of medications called Janus kinase (JAK) inhibitors, which work by blocking the JAK enzyme responsible for inflammation in the body. By inhibiting this enzyme, abrocitinib reduces inflammation and alleviates the symptoms of atopic dermatitis. However, it is not considered a first-line treatment due to a black box warning from the FDA related to serious potential side effects, including the risk of cancer and infections. Common side effects include nausea, cold symptoms, and headaches. Always consult with a healthcare professional before starting any new medication.
Price history for Cibinqo
30 Tablets, 100MG
Average retail price for Cibinqo
Average SaveHealth price for Cibinqo
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Cibinqo dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 50MG | 30 Tablets | $6,100.14 | $203.34 |
| 100MG | 30 Tablets | $5,929.77 | $197.66 |
| 200MG | 30 Tablets | $6,100.14 | $203.34 |
Cibinqo FAQs
CIBINQO is used for the treatment of moderate-to-severe atopic dermatitis, also known as eczema, in adults who are candidates for systemic therapy.
The cost of CIBINQO, like many other medications, can be attributed to several factors. These include the research and development expenses involved in bringing the drug to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, pricing can be influenced by the drug's effectiveness, the complexity of its manufacturing process, and market exclusivity granted by patents. Pharmaceutical companies also consider the potential market size and competition when setting prices.
Yes, CIBINQO (abrocitinib) does have a black box warning. It includes warnings about the risk of serious infections, mortality, malignancy, major adverse cardiovascular events, and thrombosis. It is important for patients to discuss these risks with their healthcare provider before starting the medication.
The cost of CIBINQO can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage prescribed. It is recommended to check with local pharmacies or consult with an insurance provider for the most accurate and up-to-date pricing information.
Coverage for CIBINQO under Medicare can vary depending on the specific plan. Medicare Part D or Medicare Advantage plans with prescription drug coverage may include CIBINQO, but it is essential to check the formulary of the specific plan to confirm its inclusion. Patients should contact their plan provider or consult the Medicare Plan Finder for detailed information on coverage and potential out-of-pocket costs.